Inflammation: A key player linking obesity with malignancies

Metabolism. 2018 Apr:81:A3-A6. doi: 10.1016/j.metabol.2017.12.015. Epub 2018 Jan 6.

Authors

Chrysoula Boutari¹, Christos S Mantzoros²

Affiliations

¹ Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: chrisoulabgr@yahoo.gr.
² Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

PMID: 29309747
DOI: 10.1016/j.metabol.2017.12.015

No abstract available

Keywords: Adiponectin; Cancer; Cardiovascular disease; Inflammation; Insulin resistance; Malignancies; Obesity.

Publication types

Editorial
Comment

MeSH terms

Adiponectin
Humans
Inflammation*
Insulin Resistance
Neoplasms
Obesity*

Substances

Adiponectin